anti-TACSTD2 antibody product blog
Tags: Antibody; Monoclonal Antibody; anti-TACSTD2 antibody; TACSTD2; TROP-2;
The TACSTD2 tacstd2 (Catalog #MBS604716) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The TROP-2 (Tumor-associated Calcium Signal Transducer 2, ACSTD2, GA733 Tumor Associated Antigen, Epithelial Glycoprotein-1, EGP-1) (APC) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s TROP-2 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS).Suitable for Flow Cytometry. Researchers should empirically determine the suitability of the TACSTD2 tacstd2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TACSTD2 tacstd2 product has the following accession number(s) (GI #166795236) (NCBI Accession #NP_002344.2) (Uniprot Accession #P09758). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the TROP-2 (Tumor-associated Calcium Signal Transducer 2, ACSTD2, GA733 Tumor Associated Antigen, Epithelial Glycoprotein-1, EGP-1) (APC) with the following immunoassay(s):
Flow Cytometry (FC/FACS) (Flow cytometric analysis of TROP-2 in PC-3 human prostate cancer cell line using MBS604716 (filled histogram) or isotype control antibody (open histogram).)
TROP-2, also named tumor-associated calcium signal transducer 2 (TACSTD2), GA733 tumor associated antigen, and epithelial glycoprotein-1 (EGP-1), is a type I transmembrane protein highly expressed in carcinomas.
Cell surface expression of TROP-2 is determined by flow cytometry using 620-650 nm wavelength excitation and monitoring emitted fluorescence with a detector optimized to collect peak emissions at 660-670 nm.
Immunogen: NS0-derived, recombinant human TROP-2 extracellular domain, aa 27-274; P09758. Hybridoma: Mouse myeloma with B cells obtained from a mouse immunized with purified, NS0-derived, recombinant human TROP-2 extracellular domain (rhTROP-2; aa 27-274; Accession # P09758). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TACSTD2 are readily searchable from our website. Different antibodies against the same target such as TACSTD2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Adenocarcinoma, Breast Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms, Experimental, Ovarian Diseases, Ovarian Neoplasms, Prostatic Diseases, Prostatic Neoplasms are some of the diseases may be linked to TROP-2 (Tumor-associated Calcium Signal Transducer 2, ACSTD2, GA733 Tumor Associated Antigen, Epithelial Glycoprotein-1, EGP-1) (APC).